pneumococcal polysaccharide vaccine
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
... this vaccine has been used for people over 65 years with clinical risk to develop pneumococcal infection since ...23-valent pneumococcal polysaccharide ...second-generation pneumococcal ...
10
Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine in Elderly Residents of a Long-Term Care Facility
... 23-valent pneumococcal polysaccharide vaccine and the persistence of antibodies two years after the vaccination in an elderly population in Santiago, ...the pneumococcal or a tetanus control ...
5
Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.
... Chromosomal bacterial DNA was isolated from stored swab solution and plyNCR PCR was performed as described previously [19]. In order to estimate the amount of pneumococcal DNA in swab samples as a surrogate for ...
8
Rev. Saúde Pública vol.43 número6
... with pneumococcal polysaccharide vaccine in the last trimester of pregnancy (n=42); and immunized with the vaccine immediately after childbirth ...
5
Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital
... 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine ...yielded pneumococcal isolates. The theoretical vaccine coverage ...
6
Sao Paulo Med. J. vol.132 número4
... zoster vaccine versus placebo; one study compared high-potency zoster vaccine versus low-potency zoster vaccine; one study compared refrigerated zoster vaccine versus frozen zoster ...
1
Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients
... with polysaccharide vaccines has been recom- mended as a diagnostic tool to evaluate patient ability to respond to those antigens ...evaluated pneumococcal serotype antibodies before and after immunization ...
6
Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.
... Background. Pneumococcal diseases—illnesses caused by Streptococcus pneumoniae bacteria—are leading causes of illness and death around the ...invasive pneumococcal diseases (IPDs) are often ...from ...
13
Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.
... of pneumococcal carriage, IPD and antimicrobial resistance that are crucial for vaccination impact ...global vaccine preventable invasive bacterial disease (VP-IBD’s) 3-tiered ap- proach to sentinel ...
9
Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.
... There are several advantages to such a non-genomic approach to immunodominant antigen identification; namely, this method eliminates the need to generate a comprehensive antigenic expression library. The method used here ...
7
Scientific Institutions in Latin America : The Butantan Institute
... serum and vaccine; pneumonia serum and vaccine; gangrene serum; serum for the treatment of whooping-cough; smallpox vaccine; pyogenic vaccine; streptococcus serum and[r] ...
5
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.
... a pneumococcal vaccination programme targeting those aged 65 years and over using the 23-valent polysaccha- ride vaccine (PPV23) which covers 23 of the 90+ known pneumococcal ...against ...
14
Rev. paul. pediatr. vol.34 número4
... even polysaccharide vaccines were established and maintained with high vaccination coverage, the reduction of invasive pneumococcal disease is signifi- cant; the same result was found in this study, which ...
7
Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
... with pneumococcal IgG in children in PIENTER2 were similar as the determinants found in PIENTER1, which indicated that the determinants of pneumococcal encounters did not change over time in the ...
17
Cad. Saúde Pública vol.31 número2
... The use of secondary data in epidemiologi- cal studies can pose limitations, prone to biases, ranging from case capture to data entry. In addi- tion, ecological analyses are not indicated for de- termining causality, ...
9
Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the national immunization program
... polyvalent polysaccharide vaccine, PPV23, comprises only T-cell-independent antigens and therefore induces only B-cells that are short-lived and produce low-affinity ...This vaccine is recommended ...
6
Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?
... Urogenital schistosomiasis affects 112 million people, mostly in sub-Saharan Africa, the Mid- dle East, and, most recently, Corsica [1,2]. This disease is spreading to new areas despite efforts to eradicate the ...
3
Genetic requirement for pneumococcal ear infection.
... a pneumococcal OM ...for pneumococcal infections in other ...described pneumococcal pilus ...some pneumococcal strains/clones [40], our preliminary sequencing analysis identified all of the ...
9
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.
... to polysaccharide capsule following ...serum polysaccharide responses in 5/6 volunteers [25] suggesting colonisation has a greater systemic immunising effect compared to ...challenge. Polysaccharide ...
15
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
... invasive pneumococcal dis- ease ...7-valent pneumococcal conjugate vaccine (PCV7) for infants in the Netherlands dramatically decrease SP carriage and IPD for its seven serotypes [4–10], in line with ...
16